Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap
Decision snapshot: LGND stock price vs IBM: inconclusive — current versus $162.56 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IBM's multiple
Implied fair value · at LGND's multiple
Needs LGND P/E.
As of 2025-12-31
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: LGND FY 2025 (ended Dec 31, 2025) · IBM FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 82% equity / 18% debt · EV / Revenue 4.83x · EV / EBITDA 15.66x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
LIGAND PHARMACEUTICALS INCORPORATED · implied price per share
Bear
$101.45
Base
$119.35
Bull
$137.25
INTERNATIONAL BUSINESS MACHINES CORP · implied price per share
Bear
$110.58
Base
$130.10
Bull
$149.61
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.25x
1.88x
Net debt / EBITDA
Leverage against operating earnings
-2.31x
2.26x
Cash and equivalents
Liquid reserves on the balance sheet
$733.52M
$14.20B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Royalty Pharma plc
LGND vs RPRX
Sarepta Therapeutics, Inc.
LGND vs SRPT
INCYTE CORP
LGND vs INCY
EXELIXIS, INC.
LGND vs EXEL
Microsoft Corporation
LGND vs MSFT
Oracle Corporation
LGND vs ORCL
Cisco Systems, Inc.
LGND vs CSCO
Cognizant Technology Solutions Corporation
LGND vs CTSH
$252.03M
$61.26B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
